Dr. Eva Feldman to headline fall Health Science Lecture
Dr. Eva Feldman will headline the fall Health Science Lecture on Wednesday, Oct. 2, with an update on her landmark trial of a stem cell therapy for ALS. The trial, in which patients receive the surgical implantation of stem cells directly to their spinal cords, is expected to move into Phase 2 this fall in Ann Arbor.
The lecture takes place from 6-7 p.m. in the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building on the University of Michigan campus. It is open to the general public; no registration is required. Click here for directions.
The Health Science Lecture Series is sponsored by the Taubman Institute, the Program for Biology and a number of student organizations. The lectures will be held quarterly on the U-M campus and will focus on a wide variety of topics including medical research, public health, bioethics, evolutionary biology, epidemiology and many others.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
U-M statement on the passing of A. Alfred Taubman
We have lost a dear friend and educational partner, one of the genuine leaders and best.
Taubman Scholars: Reflections on Alfred Taubman
Eminent scientists say his curiosity, interest and vision changed the course of medical science.
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.